Refractive ErrorNCT01198600
Ocular Comfort and the "Aging" Lens (ERBIUM)
A study testing Habitual contact lens, Lotrafilcon B contact lens and Contact lens cleaning and disinfecting system (ClearCare) in people with Refractive Error, run by CIBA VISION at 1 site in Canada.
Trial summary
The purpose of this trial was to evaluate the factors affecting comfortable contact lens wear and how those factors affect contact lens replacement frequency. Read more about this study
- Who is it for?
- Ages 17 years and older
- Conditions the study is for
- Refractive Error
- What is being tested?
- Habitual contact lens, Lotrafilcon B contact lens and Contact lens cleaning and disinfecting system (ClearCare)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 78 participants
- Where
- 1 siteCanada
- Study dates
- Jul 2010to Jul 2011
- Phase
- Interventional
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 17 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- At least 17 years of age.
- Ocular exam in the last two years.
- Currently wearing hydrogel or silicone hydrogel contact lenses on a daily wear basis with a monthly replacement schedule.
- Wearing contact lenses at least five days per week for a minimum of 10 hours each day.
- Able to wear lenses in the available power range with a best-corrected visual acuity of at least 20/32 in both eyes.
- Other protocol-defined inclusion criteria may apply.
Who cannot join
- Any ocular disease.
- Systemic condition that may affect a study outcome.
- Using any systemic or topical medications that may affect ocular health.
- Wears lenses on an extended or continuous wear schedule.
- Habitually wears multifocal lenses.
- Other protocol-defined exclusion criteria may apply.
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this trial was to evaluate the factors affecting comfortable contact lens wear and how those factors affect contact lens replacement frequency.
Read the detailed description
Eligible participants began Phase 1, following either Cycle A or Cycle B, and crossing over to the second cycle after completing the first. After the Phase 1 results were evaluated, eligible participants entered Phase 2. After Phase 2 results were evaluated, participants who consistently reported the highest and the lowest comfort scores entered Phase 3 and were defined as either survivors or strugglers.
- Conditions
- Refractive Error
- Being tested
- Habitual contact lens, Lotrafilcon B contact lens, Contact lens cleaning and disinfecting system (ClearCare)
- Medical subject headings
- Refractive Errors
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Habitual contact lensDevice
Hydrogel or silicone hydrogel contact lens per participant's habitual brand and prescription
Lotrafilcon B contact lensDevice
Also called AIR OPTIX AQUA
Commercially marketed silicone hydrogel contact lens
Contact lens cleaning and disinfecting system (ClearCare)Device
Also called CLEARCARE
Commercially marketed, hydrogen peroxide-based contact lens care system
| Study group | Role | What they receive |
|---|---|---|
| Phase 1: Habitual no Replacement, then Habitual Replacement | Other | Contact lenses per participant's habitual prescription worn for 30 days with no replacement, followed by contact lenses per habitual prescription worn for 30 days with a replacement pair dispensed at Day 28. Receives: Device: Habitual contact lens |
| Phase 1: Habitual Replacement, then Habitual no Replacement | Other | Contact lenses per participant's habitual prescription worn for 30 days with replacement pair dispensed at Day 28, followed by contact lenses per habitual prescription worn for 30 days with no replacement. Receives: Device: Habitual contact lens |
| Phase 2: Lotrafilcon B Replacement | Other | Contact lenses worn for 56 days with replacement pair dispensed at Day 28. Receives: Device: Lotrafilcon B contact lens; Device: Contact lens cleaning and disinfecting system (ClearCare) |
| Phase 3: Lotrafilcon B Replacement Replacement | Other | Contact lenses worn for 43 days with replacement pair dispensed at Day 1 and Day 28. Receives: Device: Lotrafilcon B contact lens; Device: Contact lens cleaning and disinfecting system (ClearCare) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Phase 3: Ocular Comfort, Lens Age 1 Day, Hour 1
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 1 day. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 1
Phase 3: Ocular Comfort, Lens Age 1 Day, Hour 10
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 1 day. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 1
Phase 3: Ocular Comfort, Lens Age 1 Day, End of Day
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 1 day. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 1
Phase 3: Ocular Comfort, Lens Age 14 Days, Hour 1
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 14 days. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 15
Phase 3: Ocular Comfort, Lens Age 14 Days, Hour 10
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 14 days. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 15
Phase 3: Ocular Comfort, Lens Age 14 Days, End of Day
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 14 days. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 15
Phase 3: Ocular Comfort, Lens Age 27 Days, Hour 1
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 27 days. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 43
Phase 3: Ocular Comfort, Lens Age 27 Days, Hour 10
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 27 days. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 43
Phase 3: Ocular Comfort, Lens Age 27 Days, End of Day
Ocular comfort was rated bilaterally by the participant after wearing the same pair of lenses for 27 days. Ocular comfort was recorded on a continuum and converted to a 100-point scale where 1=EXTREMELY UNCOMFORTABLE ("I CANNOT tolerate the comfort of my eyes! I am in pain!")and 100=VERY COMFORTABLE \& FRESH ("Wow! My eyes feel incredible! I love this feeling.")
Measured: Day 43
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted10 Sep 2010 (estimated)
- Study startJul 2010
- Primary completionJul 2011
- Study completionJul 2011
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Refractive ErrorStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Crossover
- Masking
- None (open label)
- Enrolment
- 78 participants (actual)
Sponsor and investigators
- Lead sponsor
- CIBA VISION
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- University of Waterloo
- Responsible party
- Sponsor
- Investigators
- Desmond Fonn, MOptom FAAO, Study director, University of Waterloo Centre for Contact Lens Research
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01198600
- Sponsor's protocol ID
- P-373-C-006
- Status last verified
- Jul 2012
- First submitted
- 9 Sep 2010
- Last updated
- 29 Aug 2012
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No